| Kelly R Burse, MD | |
|
3201 Middle Dr, Columbus, IN 47203-4427 | |
| (812) 372-8281 | |
| (812) 372-4525 |
| Full Name | Kelly R Burse |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 3201 Middle Dr, Columbus, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063618445 | NPI | - | NPPES |
| 200886140 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11012345 (Indiana) | Secondary |
| 207Q00000X | Family Medicine | 01064404A (Indiana) | Secondary |
| 207Q00000X | Family Medicine | 01064404 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly R Burse, MD 2502 25th St, Columbus, IN 47201-3728 Ph: (812) 372-8883 | Kelly R Burse, MD 3201 Middle Dr, Columbus, IN 47203-4427 Ph: (812) 372-8281 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
A team of scientists in Germany recently evaluated the specificities and sensitivities of different serological assays for detecting antibodies against SARS-CoV-2.
People with chronic illnesses can experience great difficulties in prison, but people such as drug addicts and the homeless may find their healthcare improves, according to a study in the latest Journal of Advanced Nursing.
AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.
Engaging in brief, cognitive-behavioral therapy is an effective treatment for helping people with problematic caffeine use lower their caffeine consumption, according to a new study coauthored by Laura M. Juliano, Ph.D., a professor of psychology at American University.
› Verified 9 days ago
David Rau, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3201 Middle Dr, Columbus, IN 47203 Phone: 812-378-7474 Fax: 812-378-7462 | |
Richard Miethke, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2502 25th St, Columbus, IN 47201 Phone: 812-372-8883 Fax: 812-372-8964 | |
Dr. Tracy Lynn Salinas, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3201 Middle Road, Columbus, IN 47203 Phone: 812-372-8281 Fax: 812-372-4525 | |
Mr. John Lacari Nieters, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2753 Fox Pointe Dr, Columbus, IN 47203 Phone: 812-376-9291 Fax: 812-378-8390 | |
Brian J Niedbalski, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4001 W Goeller Blvd Ste A, Columbus, IN 47201 Phone: 812-375-3330 Fax: 812-375-3329 | |
Mary Beth Hensley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3015 10th St, Columbus, IN 47201 Phone: 812-372-8426 |